JACOBS LEVY EQUITY MANAGEMENT, INC

Position in RCUS — Arcus Biosciences, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in RCUS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,295,473

-$12,865,974 QoQ

Shares Held

430,346

-53.7% QoQ

Ownership

0.342%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,368,973 across 85 Biotechnology names. RCUS ranks #13 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	214,160	$165,468,582
2	INCY	Incyte Corp	1,717,978	$161,696,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	212,204	$70,211,937
4	HALO	Halozyme Therapeutics, Inc.	789,429	$51,020,796
5	RARE	Ultragenyx Pharmaceutical Inc.	1,431,071	$29,980,937
6	EXEL	Exelixis, Inc.	425,982	$18,270,367
7	AUPH	Aurinia Pharmaceuticals Inc.	1,097,189	$16,260,340
8	ARVN	Arvinas, Inc.	1,441,521	$15,280,122

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,295,473	430,346	-53.7%	Shares	Sole	2026-05-15
2025-12-31	$22,161,447	929,981	-17.0%	Shares	Sole	2026-02-13
2025-09-30	$15,232,843	1,120,062	+39.1%	Shares	Sole	2025-11-17
2025-06-30	$6,555,182	805,305	-17.2%	Shares	Sole	2025-08-14
2025-03-31	$7,631,432	972,157	+108.9%	Shares	Sole	2025-05-15
2024-12-31	$6,928,376	465,304	+1871.0%	Shares	Sole	2025-02-14
2024-06-30	$359,549	23,608	-91.0%	Shares	Sole	2024-08-14
2023-12-31	$5,019,690	262,811	+89.0%	Shares	Sole	2024-02-14
2023-09-30	$2,496,109	139,059	+526.5%	Shares	Sole	2023-11-17
2020-03-31	$308,066	22,195	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.